Insider · CIK 0001212646
REARDON WILLIAM S
Reports to the SEC for 7 companies · LEXINGTON, MA
Transactions
50
Companies
7
Filings
16
CIK
0001212646
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-04-06 | THWabrdn World Healthcare FundX Exercise of In-Money | +$6,931.332 |
| 2021-04-06 | THWabrdn World Healthcare Fund · Subscription rightsX Exercise of In-Money | — |
| 2021-02-25 | THWabrdn World Healthcare FundP Purchase | +$25K |
| 2021-02-25 | THQabrdn Healthcare Opportunities FundP Purchase | +$24.9K |
| 2018-06-20 | Aceragen, Inc.Stock OptionsA Award | +$76.5K |
| 2017-07-03 | Aceragen, Inc.A Award | +$13.5K |
| 2017-06-07 | Aceragen, Inc.Stock OptionsA Award | — |
| 2016-07-01 | Aceragen, Inc.A Award | +$6,686.26 |
| 2016-06-13 | Aceragen, Inc.Stock OptionA Award | — |
| 2015-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2015-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2015-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2015-06-08 | Aceragen, Inc.Stock OptionA Award | — |
| 2014-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2014-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2014-07-01 | Aceragen, Inc.A Award | +$6,687.29 |
| 2014-06-30 | HQLabrdn Life Sciences InvestorsP Purchase | +$3,950 |
| 2013-11-13 | MDGLMADRIGAL PHARMACEUTICALS, INC.P Purchase | +$50K |
| 2013-09-16 | Aceragen, Inc.P Purchase | +$24.6K |
| 2013-08-16 | Aceragen, Inc.Stock OptionA Award | — |
| 2013-07-26 | Aceragen, Inc.Stock OptionA Award | — |
| 2013-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2013-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2012-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2012-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2012-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2012-06-12 | Aceragen, Inc.Stock OptionA Award | — |
| 2012-03-09 | HQLabrdn Life Sciences InvestorsP Purchase | +$10.2K |
| 2012-03-09 | HQHabrdn Healthcare InvestorsP Purchase | +$10.2K |
| 2011-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2011-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2011-06-14 | Aceragen, Inc.Stock OptionA Award | — |
| 2010-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2010-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2010-06-15 | Aceragen, Inc.Stock OptionA Award | — |
| 2009-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2009-07-01 | MDGLMADRIGAL PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2009-06-16 | Aceragen, Inc.Stock Option (Right to Buy)A Award | — |
| 2009-04-01 | Aceragen, Inc.A Award | +$6,687.5 |
| 2008-01-02 | Aceragen, Inc.P Purchase | +$1,749.64 |
| 2007-10-01 | Aceragen, Inc.Stock OptionsA Award | — |
| 2007-10-01 | Aceragen, Inc.P Purchase | +$1,749.725 |
| 2007-07-02 | Aceragen, Inc.P Purchase | +$2,501.856 |
| 2007-07-01 | Aceragen, Inc.Stock OptionsA Award | — |
| 2007-06-30 | MDGLMADRIGAL PHARMACEUTICALS, INC.A Award | — |
| 2007-06-07 | OSCIENT PHARMACEUTICALS CORPA Award | — |
| 2007-06-07 | OSCIENT PHARMACEUTICALS CORPStock Options (right to buy)A Award | — |
| 2007-01-01 | Aceragen, Inc.stock optionsA Award | — |
| 2006-07-06 | Aceragen, Inc.P Purchase | +$2,501.338 |
| 2006-07-01 | Aceragen, Inc.Stock optionsA Award | — |
Recent filings
- 4REARDON WILLIAM S0001104659-21-048074SEC(opens sec.gov)
- 4REARDON WILLIAM S0001104659-21-030169SEC(opens sec.gov)
- 4REARDON WILLIAM S0001104659-21-030170SEC(opens sec.gov)
- 4REARDON WILLIAM S0001179110-18-008940SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001179110-17-010204SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001179110-17-008809SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001179110-16-027486SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001179110-16-026509SEC(opens sec.gov)
- 4SYNTA PHARMACEUTICALS CORP0001179110-15-010914SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001209191-15-052007SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001209191-14-046023SEC(opens sec.gov)
- 4SYNTA PHARMACEUTICALS CORP0001179110-14-011434SEC(opens sec.gov)
- 4H&Q LIFE SCIENCES INVESTORS0001104659-14-049754SEC(opens sec.gov)
- 4SYNTA PHARMACEUTICALS CORP0001179110-13-016609SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001209191-13-044637SEC(opens sec.gov)
- 4IDERA PHARMACEUTICALS, INC.0001209191-13-041243SEC(opens sec.gov)
Companies
Address
C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE
LEXINGTON, MA, 02421